Chapter title |
Aging and Vision
|
---|---|
Chapter number | 52 |
Book title |
Retinal Degenerative Diseases
|
Published in |
Advances in experimental medicine and biology, January 2016
|
DOI | 10.1007/978-3-319-17121-0_52 |
Pubmed ID | |
Book ISBNs |
978-3-31-917120-3, 978-3-31-917121-0
|
Authors |
Marcel V. Alavi, Alavi, Marcel V. |
Abstract |
Aging involves defined genetic, biochemical and cellular pathways that regulate lifespan. These pathways are called longevity pathways and they have relevance for many age-related diseases. In the eye, longevity pathways are involved in the major blinding diseases, cataract, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy. Pharmaceutical targeting of longevity pathways can extend healthy lifespan in laboratory model systems. This offers the possibility of therapeutic interventions to also delay onset or slow the progression of age-related eye diseases. I suggest that retinal degeneration may be viewed as accelerated aging of photoreceptors and that interventions extending healthy lifespan may also slow the pace of photoreceptor loss. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Australia | 1 | <1% |
Canada | 1 | <1% |
Unknown | 104 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 18 | 17% |
Student > Ph. D. Student | 17 | 16% |
Researcher | 15 | 14% |
Student > Master | 8 | 7% |
Student > Postgraduate | 5 | 5% |
Other | 23 | 21% |
Unknown | 21 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 28% |
Psychology | 8 | 7% |
Nursing and Health Professions | 7 | 7% |
Engineering | 7 | 7% |
Agricultural and Biological Sciences | 6 | 6% |
Other | 25 | 23% |
Unknown | 24 | 22% |